IDEAS home Printed from https://ideas.repec.org/a/wly/riskan/v23y2003i1p5-17.html

A Revised Economic Analysis of Restrictions on the Use of Cell Phones While Driving

Author

Listed:
  • Joshua T. Cohen
  • John D. Graham

Abstract

Evidence that cell phone use while driving increases the risk of being involved in a motor vehicle crash has led policymakers to consider prohibitions on this practice. However, while restrictions would reduce property loss, injuries, and fatalities, consumers would lose the convenience of using these devices while driving. Quantifying the risks and benefits associated with cell phone use while driving is complicated by substantial uncertainty in the estimates of several important inputs, including the extent to which cell phone use increases a driver's risk of being involved in a crash, the amount of time drivers spend using cell phones (and hence their aggregate contribution to crashes, injuries, and fatalities), and the incremental value to users of being able to make calls while driving. Two prominent studies that have investigated cell phone use while driving have concluded that the practice should not be banned. One finds that the benefits of calls made while driving substantially exceed their costs while the other finds that other interventions could reduce motor vehicle injuries and fatalities (measured in terms of quality adjusted life years) at a lower cost. Another issue is that cell phone use imposes increased (involuntary) risks on other roadway users. This article revises the assumptions used in the two previous analyses to make them consistent and updates them using recent data. The result is a best estimate of zero for the net benefit of cell phone use while driving, a finding that differs substantially from the previous study. Our revised cost‐effectiveness estimate for cell phone use while driving moves in the other direction, finding that the cost per quality adjusted life year increases modestly compared to the previous estimate. Both estimates are very uncertain.

Suggested Citation

  • Joshua T. Cohen & John D. Graham, 2003. "A Revised Economic Analysis of Restrictions on the Use of Cell Phones While Driving," Risk Analysis, John Wiley & Sons, vol. 23(1), pages 5-17, February.
  • Handle: RePEc:wly:riskan:v:23:y:2003:i:1:p:5-17
    DOI: 10.1111/1539-6924.00286
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/1539-6924.00286
    Download Restriction: no

    File URL: https://libkey.io/10.1111/1539-6924.00286?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Dennis G. Fryback & Erik J. Dasbach & Ronald Klein & Barbara E.K. Klein & Norma Dorn & Kathy Peterson & Patrica A. Martin, 1993. "The Beaver Dam Health Outcomes study," Medical Decision Making, , vol. 13(2), pages 89-102, June.
    2. Donald A. Redelmeier & Milton C. Weinstein, 1999. "Cost—Effectiveness of Regulations against Using a Cellular Telephone while Driving," Medical Decision Making, , vol. 19(1), pages 1-8, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Mathew P. White & J. Richard Eiser & Peter R. Harris, 2004. "Risk Perceptions of Mobile Phone Use While Driving," Risk Analysis, John Wiley & Sons, vol. 24(2), pages 323-334, April.
    2. Michael Greenberg & Anthony Cox & Vicki Bier & Jim Lambert & Karen Lowrie & Warner North & Michael Siegrist & Felicia Wu, 2020. "Risk Analysis: Celebrating the Accomplishments and Embracing Ongoing Challenges," Risk Analysis, John Wiley & Sons, vol. 40(S1), pages 2113-2127, November.
    3. Richard A. Young & Christopher Schreiner, 2009. "Real‐World Personal Conversations Using a Hands‐Free Embedded Wireless Device While Driving: Effect on Airbag‐Deployment Crash Rates," Risk Analysis, John Wiley & Sons, vol. 29(2), pages 187-204, February.
    4. Mara Faccio & John J. McConnell, 2020. "Death by Pokémon GO: The Economic and Human Cost of Using Apps While Driving," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 87(3), pages 815-849, September.
    5. David M. Hassenzahl, 2006. "Implications of Excessive Precision for Risk Comparisons: Lessons from the Past Four Decades," Risk Analysis, John Wiley & Sons, vol. 26(1), pages 265-276, February.
    6. Kolko, Jed, 2007. "Dialing While Fishtailing: How Mobile Phones, Hands-Free Laws, and Driving Conditions Interact to Affect Traffic Fatalities," MPRA Paper 4135, University Library of Munich, Germany.
    7. J. Bradley Karl & Charles M. Nyce & Lawrence Powell & Boyi Zhuang, 2023. "How risky is distracted driving?," Journal of Risk and Uncertainty, Springer, vol. 66(3), pages 279-312, June.
    8. James Hunton & Jacob M. Rose, 2005. "Cellular Telephones and Driving Performance: The Effects of Attentional Demands on Motor Vehicle Crash Risk," Risk Analysis, John Wiley & Sons, vol. 25(4), pages 855-866, August.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Daniel Sperber & Alan Shiell & Ken Fyie, 2010. "The cost‐effectiveness of a law banning the use of cellular phones by drivers," Health Economics, John Wiley & Sons, Ltd., vol. 19(10), pages 1212-1225, October.
    2. Hirsch Ruchlin & Ralph Insinga, 2008. "A Review of Health-Utility Data for Osteoarthritis," PharmacoEconomics, Springer, vol. 26(11), pages 925-935, November.
    3. Louis S. Matza & Katherine J. Kim & Holly Yu & Katherine A. Belden & Antonia F. Chen & Mark Kurd & Bruce Y. Lee & Jason Webb, 2019. "Health state utilities associated with post-surgical Staphylococcus aureus infections," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(6), pages 819-827, August.
    4. Nicholas E. Burger & Daniel T. Kaffine & Bo Yu, 2013. "Did California's hand-held cell phone ban reduce accidents?," Working Papers 2013-08, Colorado School of Mines, Division of Economics and Business.
    5. Stavros Petrou & Christine Hockley, 2005. "An investigation into the empirical validity of the EQ‐5D and SF‐6D based on hypothetical preferences in a general population," Health Economics, John Wiley & Sons, Ltd., vol. 14(11), pages 1169-1189, November.
    6. Don Kenkel, 2006. "WTP- and QALY-Based Approaches to Valuing Health for Policy: Common Ground and Disputed Territory," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 34(3), pages 419-437, July.
    7. John Anderson & Robert Kaplan & Christopher Ake, 2004. "Arthritis Impact on U.S. Life Quality: Morbidity and Mortality Effects From National Health Interview Survey Data 1986–1988 and 1994 Using QWBX1 Estimates of Well-Being," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 69(1), pages 67-91, October.
    8. Costa-Font, Montserrat & Costa-Font, Joan, 2009. "Heterogeneous 'adaptation' and 'income effects' across self-reported health distribution?," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 38(4), pages 574-580, August.
    9. Harris, Ryan A. & Nease, Robert Jr., 1997. "The importance of patient preferences for comorbidities in cost-effectiveness analyses," Journal of Health Economics, Elsevier, vol. 16(1), pages 113-119, February.
    10. Patricia Cubí‐Mollá & Carmen Herrero, 2012. "Quality of life lost due to non‐fatal road traffic injuries," Health Economics, John Wiley & Sons, Ltd., vol. 21(5), pages 528-550, May.
    11. Kibum Kim & Gwendolyn A McMillin & Philip S Bernard & Srinivas Tantravahi & Brandon S Walker & Robert L Schmidt, 2019. "Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia," PLOS ONE, Public Library of Science, vol. 14(12), pages 1-21, December.
    12. Joyce H S You & Kia K N Tsui & Raymond S M Wong & Gergory Cheng, 2012. "Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation," PLOS ONE, Public Library of Science, vol. 7(6), pages 1-9, June.
    13. Patricia Vold Pepper & Douglas K. Owens, 2002. "Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults," Medical Decision Making, , vol. 22(1_suppl), pages 45-57, September.
    14. Hans-Helmut König & Oliver Günther & Matthias Angermeyer & Christiane Roick, 2009. "Utility Assessment in Patients with Mental Disorders," PharmacoEconomics, Springer, vol. 27(5), pages 405-419, May.
    15. Michele Kohli & Cheryl Attard & Annette Lam & Daniel Huse & John Cook & Chantal Bourgault & Evo Alemao & Donald Yin & Michael Marentette, 2006. "Cost Effectiveness of Adding Ezetimibe to Atorvastatin Therapy in Patients Not at Cholesterol Treatment Goal in Canada," PharmacoEconomics, Springer, vol. 24(8), pages 815-830, August.
    16. William M Reichmann & Jeffrey N Katz & Elena Losina, 2011. "Differences in Self-Reported Health in the Osteoarthritis Initiative (OAI) and Third National Health and Nutrition Examination Survey (NHANES-III)," PLOS ONE, Public Library of Science, vol. 6(2), pages 1-7, February.
    17. Francis Marleau Donais & Irène Abi-Zeid & E. Owen D. Waygood & Roxane Lavoie, 2019. "A review of cost–benefit analysis and multicriteria decision analysis from the perspective of sustainable transport in project evaluation," EURO Journal on Decision Processes, Springer;EURO - The Association of European Operational Research Societies, vol. 7(3), pages 327-358, November.
    18. Erik Nord & Paul Menzel & Jeff Richardson, 2003. "The value of life: individual preferences and social choice. A comment to Magnus Johannesson," Health Economics, John Wiley & Sons, Ltd., vol. 12(10), pages 873-877, October.
    19. Thi-Phuong-Lan Nguyen & Paul F M Krabbe & Thi-Bach-Yen Nguyen & Catharina C M Schuiling-Veninga & E Pamela Wright & Maarten J Postma, 2015. "Utilities of Patients with Hypertension in Northern Vietnam," PLOS ONE, Public Library of Science, vol. 10(10), pages 1-9, October.
    20. James F Burke & Kenneth M Langa & Rodney A Hayward & Roger L Albin, 2014. "Modeling Test and Treatment Strategies for Presymptomatic Alzheimer Disease," PLOS ONE, Public Library of Science, vol. 9(12), pages 1-20, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:wly:riskan:v:23:y:2003:i:1:p:5-17. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: https://doi.org/10.1111/(ISSN)1539-6924 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.